The effect of relapse on cognition in abstinent methamphetamine abusers

Journal of Substance Abuse Treatment
Sara L SimonWalter Ling

Abstract

Data from 75 participants in a longitudinal study of methamphetamine (MA) abuse were used to differentiate the cognitive performance of those who remained abstinent, relapsed, or continued to use during treatment. Participants were divided into three groups: continuous abstinence, initial abstinence but relapse, and continuous use. Groups did not differ on age, education, gender or ethnicity. Participants in the longitudinal study completed a battery of cognitive tests within 7 days of their last use of MA, then were re-tested monthly for up to 6 months (average time for this analysis was 92 days). For episodic memory, the relapse groups performance was worse than the abstinent and significantly worse than that of the continued use group who had the best performance on all measures. Relapse to methamphetamine use may affect episodic memory differently than it affects the other cognitive functions measured.

References

Mar 1, 1988·Journal of Studies on Alcohol·S L SchandlerA Hassell
Nov 1, 1994·Addiction·M A Schuckit
Nov 1, 1994·Addiction·C P O'Brien
Jan 1, 1994·The American Journal of Drug and Alcohol Abuse·E A WellsR F Catalano
Jul 3, 1998·Drug and Alcohol Dependence·R McKetin, R P Mattick
Jul 25, 2000·Journal of Psychoactive Drugs·M L BrechtM D Anglin
Sep 23, 2000·The American Journal on Addictions·S L SimonW Ling
Mar 7, 2001·The American Journal of Psychiatry·N D VolkowJ Logan
Mar 28, 2002·Journal of Addictive Diseases·Susan EgelkoGeorge De Leon
Aug 31, 2002·Addictive Behaviors·Gordon TeichnerAngelica Thevos
May 2, 2003·The Journal of Neuropsychiatry and Clinical Neurosciences·Ari D KalechsteinMichael Green

❮ Previous
Next ❯

Citations

Jan 25, 2008·Applied Psychophysiology and Biofeedback·Tato M SokhadzeDavid L Trudeau
Aug 19, 2007·Neuropsychology Review·J Cobb ScottIgor Grant
Dec 15, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carmela M ReichelRonald E See
Sep 6, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andy C DeanEdythe D London
Aug 21, 2007·Journal of Psychoactive Drugs·Charles W MeredithAndrew J Saxon
Mar 4, 2010·Journal of Clinical and Experimental Neuropsychology·Jennifer E IudicelloUNKNOWN HIV Neurobehavioral Research Center (HNRC) Group
Nov 30, 2011·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Ruth SaloCatherine Fassbender
Feb 9, 2012·The Australian and New Zealand Journal of Psychiatry·Erin E MorganUNKNOWN Translational Methamphetamine Research Center (TMARC) group
Oct 1, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Motohiro NakajimaMustafa Al'Absi
Feb 3, 2016·Frontiers in Psychiatry·Jean Lud Cadet, Veronica Bisagno
May 9, 2012·Drug and Alcohol Dependence·Erica WeberUNKNOWN Translational Methamphetamine AIDS Research Center (TMARC) Group
Nov 26, 2011·Neuropharmacology·Carmela M ReichelRonald E See
Feb 1, 2011·Behavioural Brain Research·Hiroyuki MizoguchiKiyofumi Yamada
Jun 18, 2010·Journal of Ethnopharmacology·Richard Hoffman, Mustafa Al'Absi
Apr 3, 2009·Journal of Substance Abuse Treatment·Ruth SaloMartin H Leamon
Mar 31, 2009·Brain Research Reviews·Irina N Krasnova, Jean Lud Cadet
Jul 15, 2015·The International Journal of Neuropsychopharmacology·Paula L Vieira-BrockAnnette E Fleckenstein
Jan 4, 2012·The American Journal on Addictions·Joseph TkaczCharles Ruetsch
Jul 11, 2006·Neurotoxicology and Teratology·Lara K Aitchison, Robert N Hughes
Apr 18, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Na ZhongMin Zhao
Apr 5, 2015·Drug and Alcohol Dependence·Andy C DeanEdythe D London
Apr 14, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael D ScofieldCarmela M Reichel
Dec 31, 2011·Drug and Alcohol Dependence·Andy C DeanEdythe D London
Aug 2, 2014·Psychiatry Research·Erin E MorganUNKNOWN Translational Methamphetamine AIDS Research (TMARC) Group
Nov 3, 2016·Iranian Journal of Psychiatry and Behavioral Sciences·Bahareh AminAzadeh Mesripour
Jul 28, 2016·Neuroscience and Biobehavioral Reviews·Aurelien BernheimCarmela M Reichel
Jul 16, 2005·Harvard Review of Psychiatry·Charles W MeredithAndrew J Saxon
Apr 28, 2006·Current Opinion in Psychiatry·Jane Carlisle Maxwell
Jun 1, 2009·Journal of Addiction Medicine·Charles W MeredithAndrew J Saxon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.